|
MRK's Revenue Growth by Quarter and Year
Merck And Co Inc 's Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
MRK Revenue (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
IV Quarter |
December |
-
|
14,631.00
|
13,830.00
|
12,068.00
|
III Quarter |
September |
-
|
15,962.00
|
14,959.00
|
13,154.00
|
II Quarter |
June |
16,112.00
|
15,035.00
|
14,593.00
|
11,402.00
|
I Quarter |
March |
15,775.00
|
14,487.00
|
15,901.00
|
12,080.00
|
FY |
|
31,887.00
|
60,115.00
|
59,283.00
|
48,704.00
|
MRK Revenue second quarter 2024 Y/Y Growth Comment |
Merck and Co Inc achieved in the second quarter 2024, above Company average Revenue improvement of 7.16% year on year, to $ 16,112.00 millions.
Looking into second quarter 2024 results within Major Pharmaceutical Preparations industry 80 other companies have achieved higher Revenue growth. While Merck And Co Inc ' s Revenue increase of 7.16% ranks overall at the positon no. 1055 in the second quarter 2024.
|
MRK Revenue ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
IV Quarter |
December |
- |
5.79 % |
14.6 % |
-3.56 % |
III Quarter |
September |
- |
6.7 % |
13.72 % |
4.8 % |
II Quarter |
June |
7.16 % |
3.03 % |
27.99 % |
4.87 % |
I Quarter |
March |
8.89 % |
-8.89 % |
31.63 % |
0.19 % |
FY |
|
- |
1.4 % |
21.72 % |
1.48 % |
MRK Revenue (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
IV Quarter |
December |
- |
-8.34 % |
-7.55 % |
-8.26 % |
III Quarter |
September |
- |
6.17 % |
2.51 % |
15.37 % |
II Quarter |
June |
2.14 % |
3.78 % |
-8.23 % |
-5.61 % |
I Quarter |
March |
7.82 % |
4.75 % |
31.76 % |
-3.47 % |
FY (Year on Year) |
|
- |
1.4 % |
21.72 % |
1.48 % |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
112.1 % |
6.69 % |
-10.57 % |
(March 31, 2010) |
|
(June 30. 2013) |
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
112.1 % |
6.69 % |
-10.57 % |
(March 31, 2010) |
|
(June 30. 2013) |
|
Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Merck And Co Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
66.84 % |
1.71 % |
-10.73 % |
(Dec. 30, 2009) |
|
|
MRK's II. Quarter Q/Q Revenue Comment |
Merck and Co Inc achieved in the II. Quarter 2024 above company average sequential Revenue growth of 2.14%, to $ 16,112.00 millions, from $15,775.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 146 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 2030. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
66.84 % |
1.71 % |
-10.73 % |
(Dec. 30, 2009) |
|
|
MRK's II. Quarter Q/Q Revenue Comment |
Merck and Co Inc achieved in the II. Quarter 2024 above company average sequential Revenue growth of 2.14%, to $ 16,112.00 millions, from $15,775.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 146 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 2030. |
|
Merck And Co Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Jun 30 2024) |
12 Months Ending (Mar 31 2024) |
12 Months Ending (Dec 31 2023) |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
Cumulative Revenue 12 Months Ending |
$ 62,480.00 |
$ 61,403.00 |
$ 60,115.00 |
$ 59,314.00 |
$ 58,311.00 |
Y / Y Revenue Growth (TTM) |
7.15 % |
6.11 % |
1.4 % |
3.12 % |
4.66 % |
Year on Year Revenue Growth Overall
Ranking |
# 477 |
# 908 |
# 268 |
# 321 |
# 2021 |
Seqeuential Revenue Change (TTM) |
1.75 % |
2.14 % |
1.35 % |
1.72 % |
0.76 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 597 |
# 1824 |
# 761 |
# 803 |
# 2642 |
Cumulative Revenue growth
Comment |
Although Merck And Co Inc 's Annual Revenue growth year on year were below company's average 7.29% , Revenue announced in the Jun 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 7.15% year on year, from 6.11% in Mar 31 2024.
In the Healthcare sector 63 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 477, from total ranking in previous quarter at 908. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
88.24 % |
7.29 % |
-7.58 % |
|
|
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
88.24 % |
7.29 % |
-7.58 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 24 |
Sector |
# 76 |
S&P 500 |
# 597 |
|
Cumulative Revenue growth
Comment |
Although Merck And Co Inc 's Annual Revenue growth year on year were below company's average 7.29% , Revenue announced in the Jun 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 7.15% year on year, from 6.11% in Mar 31 2024.
In the Healthcare sector 63 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 477, from total ranking in previous quarter at 908. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
88.24 % |
7.29 % |
-7.58 % |
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
88.24 % |
7.29 % |
-7.58 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 24 |
Sector |
# 76 |
S&P 500 |
# 597 |
|